Upcoming Drugs

In this title, I would like to write excerpt details of upcoming drugs in pharmaceutical market.
Note: The postings regarding pharmaceuticals are written from daily pharma industry news.

Compound --- Sponsor --- Indication
Clamelle (azithromycin) --- Actavis --- Chlamydia
UK approves Clamelle (azithromycin) as first over-the-counter (OTC*) antibiotic for Chlamydia**. MHRA*** announced that the pharmacist can dispense Clamelle to people 16 years of age and older who have tested positive for the bacterial infection and have no symptoms. Sexual partners of those who tested positive would also able to receive the treatment OTC. This OTC antibiotic is expected to available in the beginning later this year. Clamelle is the first time oral antibiotic is to be sold OTC in UK. Some experts said that the resistance to azithromycin is rare.
*OTC – Over-the-Counter drug that may be sold without a prescription and without a visit to a medical professional, in contrast to prescription drugs.
**Chlamydia – A sexually transmitted infection caused by bacteria of the genus Chlamydia
***MHRA – Medicines and Healthcare products Regulatory Agency



Cleviprex (clevidipine) --- The Medicine Company --- Hypertension


FDA gave approval for intravenous Cleviprex (clevidipine) for the treatment of hypertension and the product is expected to be launched in September. Unlike some available intravenous hypertension treatments, Cleviprex is metabolized in blood and tissue itself rather than kidney and liver and it doesn’t accumulate in the body. Cleviprex is the first intravenous hypertension drug to receive US regulatory approval in 10 years.